COMPANY
PAYLESS COMPOUNDERS, LLC
PAYLESS COMPOUNDERS, LLC: recalling firm for Semaglutide, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Semaglutide | Class II recall, Ongoing, 2026-04-22 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.